Novo Nordisk Profit Margin 2006-2018 | NVO

Current and historical gross margin, operating margin and net profit margin for Novo Nordisk (NVO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Novo Nordisk net profit margin as of December 31, 2018 is 34.67%.
Novo Nordisk Annual Profit Margins
Novo Nordisk Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $117.534B $17.724B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $369.784B 16.77
Pfizer (PFE) United States $232.043B 12.99
Merck (MRK) United States $198.062B 16.93
Novartis AG (NVS) Switzerland $174.174B 14.81
Eli Lilly (LLY) United States $119.606B 20.77
AbbVie (ABBV) United States $115.278B 9.88
Sanofi (SNY) France $103.709B 12.80
GlaxoSmithKline (GSK) United Kingdom $98.430B 12.93
AstraZeneca (AZN) United Kingdom $98.150B 11.20
Bristol-Myers Squibb (BMY) United States $73.920B 11.37